A prospective observational study to validate treatment strategies for patients with gastric cancer or esophagogastric junctional cancer who received chemotherapy as initial treatment
Not Applicable
Recruiting
- Conditions
- gastric cancer or esophagogastric junction cancer
- Registration Number
- JPRN-UMIN000051320
- Lead Sponsor
- Osaka International Cancer Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with uncontrolled infections (including active tuberculosis). 2) Serious complications (malignant hypertension, severe congestive heart failure, severe or unstable angina pectoris, myocardial infarction within 3 months before consent, end-stage liver cirrhosis, severe renal failure or chronic renal failure requiring hemodialysis , uncontrolled diabetes, severe pulmonary fibrosis, active interstitial pneumonia, etc.). 3) Patients after allogeneic bone marrow transplantation. 4)Patients with severe mental disorders. 5) Pregnant women, breastfeeding women, or patients who may be pregnant. 6) Patients who are otherwise judged to be ineligible by the principal investigator or co-investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method